IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 199 filers reported holding IMMUNOGEN INC in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,865,010 | -80.4% | 2,308,596 | -74.7% | 0.01% | -82.6% |
| Q4 2022 | $45,336,181 | +53.0% | 9,140,359 | +47.5% | 0.05% | +58.6% |
| Q3 2022 | $29,624,000 | +7554.8% | 6,197,480 | +3773.1% | 0.03% | – |
| Q3 2019 | $387,000 | -71.3% | 160,014 | -74.2% | 0.00% | -100.0% |
| Q2 2019 | $1,348,000 | -66.2% | 621,307 | -57.8% | 0.00% | -75.0% |
| Q1 2019 | $3,988,000 | -22.6% | 1,471,676 | +37.2% | 0.00% | -33.3% |
| Q4 2018 | $5,150,000 | -53.7% | 1,072,821 | -8.6% | 0.01% | -40.0% |
| Q3 2018 | $11,112,000 | -1.9% | 1,173,360 | +0.7% | 0.01% | -9.1% |
| Q2 2018 | $11,332,000 | – | 1,164,643 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |